Literature DB >> 19728083

Evidence for a transcriptional signature of breast cancer.

Yumei Feng1, Xiaoqing Li, Baocun Sun, Yuli Wang, Lina Zhang, Xiuhua Pan, Xiaohui Chen, Xiaoyan Wang, Jinfeng Wang, Xishan Hao.   

Abstract

Cancer arises from a step-wise accumulation of genetic and epigenetic changes in oncogenes and tumor suppressor genes, followed by changes in transcription and protein profiles. To identify the intrinsic transcriptional features of breast cancer and to explore in more detail the molecular basis of breast carcinogenesis, genes differentially expressed between cancers and their paired normal breast samples in nine breast cancer patients were screened using microarray. Nine normal breast tissues and 49 breast cancer tissue samples were then clustered based on the set of differentially expressed genes. A transcriptional signature of breast cancer consisting of 188 differentially expressed genes was identified. This signature allowed the normal breast tissues to be distinguished from all of the breast cancer samples, and primary breast cancers could be classified into two phenotype-associated subgroups with different ER status and clinical outcome. Furthermore, the classification accuracy of the set of differentially expressed genes was validated in publically available breast microarray data. Moreover, the differentially expressed genes could be grouped into five subclusters involved in different biological processes of carcinogenesis. Most genes in a given subcluster interacted within an independent subnetwork, and subnetworks could cross-talk through a set of signal molecules. Thus, the transcriptional signature identified here may be an intrinsic feature of breast cancer, and it may constitute to the molecular basis of breast carcinogenesis and different phenotypes of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728083     DOI: 10.1007/s10549-009-0505-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  7 in total

1.  Gene expression abnormalities in histologically normal breast epithelium from patients with luminal type of breast cancer.

Authors:  Pavol Zubor; Jozef Hatok; Petra Moricova; Karol Kajo; Ivana Kapustova; Andrea Mendelova; Peter Racay; Jan Danko
Journal:  Mol Biol Rep       Date:  2014-11-19       Impact factor: 2.316

2.  The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway.

Authors:  Georgios Pampalakis; Osahon Obasuyi; Olga Papadodima; Aristotelis Chatziioannou; Vassileios Zoumpourlis; Georgia Sotiropoulou
Journal:  Oncotarget       Date:  2014-05-15

3.  Breast cancer cells obtain an osteomimetic feature via epithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction.

Authors:  Cong-Cong Tan; Gui-Xi Li; Li-Duan Tan; Xin Du; Xiao-Qing Li; Rui He; Qing-Shan Wang; Yu-Mei Feng
Journal:  Oncotarget       Date:  2016-11-29

4.  FOXF2 reprograms breast cancer cells into bone metastasis seeds.

Authors:  Shuo Wang; Gui-Xi Li; Cong-Cong Tan; Rui He; Li-Juan Kang; Jun-Tao Lu; Xiao-Qing Li; Qing-Shan Wang; Pei-Fang Liu; Qiong-Li Zhai; Yu-Mei Feng
Journal:  Nat Commun       Date:  2019-06-20       Impact factor: 14.919

5.  Primary tumors release ITGBL1-rich extracellular vesicles to promote distal metastatic tumor growth through fibroblast-niche formation.

Authors:  Qing Ji; Lihong Zhou; Hua Sui; Liu Yang; Xinnan Wu; Qing Song; Ru Jia; Ruixiao Li; Jian Sun; Ziyuan Wang; Ningning Liu; Yuanyuan Feng; Xiaoting Sun; Gang Cai; Yu Feng; Jianfeng Cai; Yihai Cao; Guoxiang Cai; Yan Wang; Qi Li
Journal:  Nat Commun       Date:  2020-03-05       Impact factor: 14.919

6.  Quantitative proteomics reveals FLNC as a potential progression marker for the development of hepatocellular carcinoma.

Authors:  Yingzi Qi; Feng Xu; Lingsheng Chen; Yanchang Li; Zhongwei Xu; Yao Zhang; Wei Wei; Na Su; Tao Zhang; Fengxu Fan; Xing Wang; Xue Qin; Lingqiang Zhang; Yinkun Liu; Ping Xu
Journal:  Oncotarget       Date:  2016-10-18

7.  ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.

Authors:  Wei Huang; Demin Yu; Mingjie Wang; Yue Han; Junyu Lin; Dong Wei; Jialin Cai; Bin Li; Peizhan Chen; Xinxin Zhang
Journal:  Cell Prolif       Date:  2020-06-14       Impact factor: 6.831

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.